Cited by 93Cancer-related gene regulationRNA modifications and cancerPolyamine Metabolism and Applications

Molecular basis for substrate recruitment to the PRMT5 methylosome

Open access
Mulvaney, Kathleen M., Blomquist, Christa, Acharya, Nischal, Li, Ruitong, Ranaghan, Matthew J., O’Keefe, Meghan, Rodriguez, Diego J., Young, Michael J. +20 more·2021·Molecular Cell

Published version of a preprint

Abstract

PRMT5 is an essential arginine methyltransferase and a therapeutic target in MTAP-null cancers. PRMT5 uses adaptor proteins for substrate recruitment through a previously undefined mechanism. Here, we identify an evolutionarily conserved peptide sequence shared among the three known substrate adaptors (CLNS1A, RIOK1, and COPR5) and show that it is necessary and sufficient for interaction with PRMT5. We demonstrate that PRMT5 uses modular adaptor proteins containing a common binding motif for substrate recruitment, comparable with other enzyme classes such as kinases and E3 ligases. We structurally resolve the interface with PRMT5 and show via genetic perturbation that it is required for methylation of adaptor-recruited substrates including the spliceosome, histones, and ribosomal complexes. Furthermore, disruption of this site affects Sm spliceosome activity, leading to intron retention. Genetic disruption of the PRMT5-substrate adaptor interface impairs growth of MTAP-null tumor cells and is thus a site for development of therapeutic inhibitors of PRMT5.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2021.07.019

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two complexes, Rpl12B-Rmt2 and Rpl7A-Fpr4, involving enzymes that introduce protein modifications such as arginine methylations or proline isomerizations, provide insight into mechanisms that expand the chemical diversity of ribosomal proteins at functional sites and possibly regulate translation.

    “Two complexes, Rpl12B–Rmt2 and Rpl7A–Fpr4, involving enzymes that introduce protein modifications such as arginine methylations or proline isomerizations (47), provide insight into mechanisms that expand the chemical diversity of ribosomal proteins at functional sites (48) and possibly regulate translation (49).”

    From Computed structures of core eukaryotic protein complexes (2021) · cites this paper as [47]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mulvaney, K. M., Blomquist, C., Acharya, N., Li, R., Ranaghan, M. J., O’Keefe, M., Rodriguez, D. J., Young, M. J., Kesar, D., Pal, D., Stokes, M., Nelson, A. J., Jain, S. S., Yang, A., Mullin-Bernstein, Z., Columbus, J., Bozal, F. K., Skepner, A., Raymond, D., LaRussa, S., McKinney, D. C., Freyzon, Y., Baidi, Y., Porter, D., Aguirre, A. J., Ianari, A., McMillan, B., & Sellers, W. R.
Affiliations
  • Broad Institute (US)
  • Cell Signaling Technology (United States) (US)
  • Tango Therapeutics (United States) (US)
Corresponding author
Sellers, William R.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2021-09
Volume
81
Issue
17
Pages
3481-3495.e7
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3190829687
Cited by
93
References
66
Citations by year
2026: 10 · 2025: 32 · 2024: 12 · 2023: 19 · 2022: 15 · 2021: 5
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Broad Institute
  • National Institutes of Health (NIH-R01)
  • National Cancer Institute (F32CA232543, R01CA233626)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords
PRMT5, methylosome, protein arginine methyltransferase, substrate recruitment, adaptor proteins, RIOK1, peptide binding motifs, protein-protein interfaces, spliceosome, Sm proteins, intron retention, histone methylation, PRMT5 inhibitors
MeSH terms
Animals, Cytoplasm, Female, Histones, Humans, Ion Channels, Male, Methylation, Mice, Nude, Nuclear Proteins, Peptides, Protein-Arginine N-Methyltransferases, Protein Binding, Protein Processing, Post-Translational, Protein Serine-Threonine Kinases, Spliceosomes, HCT116 Cells, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review